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The European Society of Hypertension has recently published its recommendations on prevention, diagnosis and
treatment of high blood pressure in children and adolescents. Taking this contribution as a starting point the Study
Group of Hypertension of the Italian Society of Pediatrics together with the Italian Society of Hypertension has
conducted a reappraisal of the most recent literature on this subject. The present review does not claim to be an
exhaustive description of hypertension in the pediatric population but intends to provide Pediatricians with
practical and updated indications in order to guide them in this often unappreciated problem.
This document pays particular attention to the primary hypertension which represents a growing problem in
children and adolescents. Subjects at elevated risk of hypertension are those overweight, with low birth weight and
presenting a family history of hypertension. However, also children who do not present these risk factors may have
elevated blood pressure levels. In pediatric age diagnosis of hypertension or high normal blood pressure is made
with repeated office blood pressure measurements that show values exceeding the reference values. Blood
pressure should be monitored at least once a year with adequate methods and instrumentation and the observed
values have to be interpreted according to the most updated nomograms that are adjusted for children’s gender,
age and height. Currently other available methods such as ambulatory blood pressure monitoring and home blood
pressure measurement are not yet adequately validated for use as diagnostic instruments. To diagnose primary
hypertension it is necessary to exclude secondary forms. The probability of facing a secondary form of hypertension
is inversely proportional to the child’s age and directly proportional to blood pressure levels. Medical history, clinical
data and blood tests may guide the differential diagnosis of primary versus secondary forms. The prevention of
high blood pressure is based on correct lifestyle and nutrition, starting from childhood age. The treatment of
primary hypertension in children is almost exclusively dietary/behavioral and includes: a) reduction of overweight
whenever present b) reduction of dietary sodium intake c) increase in physical activity. Pharmacological therapy will
be needed rarely and only in specific cases.
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Before reference nomograms for blood pressure in child-
hood were available, the diagnosis of hypertension was
made only in the presence of highly elevated blood pres-
sure levels. Practically only the most severe secondary
forms were diagnosed. Through the publication of the* Correspondence: simonetta.genovesi@unimib.it
12Clinica Nefrologica e Dipartimento di Medicina Clinica e Prevenzione
Università di Milano Bicocca. Progetto PAB (Pressione Arteriosa Bambino),
Società Italiana Ipertensione Arteriosa, Milan, Italy
Full list of author information is available at the end of the article
© 2013 Spagnolo et al.; licensee BioMed Cent
Commons Attribution License (http://creativec
reproduction in any medium, provided the orfirst reference values [1] is has been possible to reveal
that there is a large number of children with blood
pressure levels above the normal range and that this
condition can be almost completely ascribed to primary
hypertension. The rise in the prevalence of overweight
children and the increased survival rate of subjects with
a very low birth weight may predict that the progression
of hypertension prevalence in pediatric subjects will
continue to aggravate. In 2009 the European Society of
Hypertension published recommendations for the man-
agement of hypertension in children and adolescents [2].ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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children with elevated blood pressure levels are destined
to become hypertensive adults [3]. Better diagnostic
techniques for detecting subclinical organ damage have
allowed us to become aware that even in childhood high
blood pressure may be accompanied by structural and
functional changes in some organs. The Italian Society
of Pediatrics and the Italian Society of Hypertension aim
at providing the recommendations that are suitable for
the Italian health care situation. These indications do
not claim to be an exhaustive description of the prob-
lems of hypertension in the years of growth, but they
intend to provide Pediatricians and Family Doctors with
updated recommendations on prevention, diagnosis and
treatment in order to prevent organ damage that might
emerge if hypertension is not properly treated. This task
however is not easy as there are no observational studies
in children on the relationship between blood pressure
values and cardiovascular events that may arise many
years later. Besides, large intervention trials in children
are lacking at the moment.
Definition
Hypertension in children is defined using a statistical
criterion, the limit being the 95th percentile of the
distribution of the systo-diastolic blood pressure values,
according to gender, age and height. In order to conform
to the adult terminology pre-hypertension or high-normal
pressure hypertension is defined as blood pressure values
consistently above or equal to the 90th percentile, but lower
than the 95th [4] (Table 1).
Figure 1 shows the algorithm to be used for a correct
diagnosis of hypertension.
Epidemiology
Prevalence and new diagnoses of hypertension in chil-
dren and adolescents are increasing [5]. Numerous
population studies indicate that a hypertensive condition
in childhood raises the probability of being hypertensive
in adulthood [3]. In the first years of childhood second-
ary forms prevail whereas with increasing age primary
forms of hypertension become most frequent. BloodTable 1 Definition and classification of hypertension in
children and adolescents
Category Systolic or diastolic blood pressure percentile
Normal < 90th
Pre-hypertension ≥ 90th and < 95th
≥ 120/80 mmHg independently of the 90th
percentile value in adolescents
Stage 1 hypertension ≥ 95th and < 99th + 5 mmHg
Stage 2 hypertension ≥ 99th + 5 mmHg
4° Report on the Diagnosis, Evaluation and Treatment of High Blood Pressure
in Children and Adolescents. Pediatrics 2004 [4].pressure values increase progressively until the age of
17–18 years when adult values are reached. This in-
crease is most rapid during the first weeks of life and
during puberty. Blood pressure values are correlated
with gender, height and body mass. Obesity represents a
strong risk factor for the development of child hyperten-
sion. There are no sufficient data on the role of ethni-
city, but many studies demonstrate that Afro-American
children have higher blood pressure values than
Caucasian children [5,6]. The heritability of childhood
hypertension is estimated to be about 50% [7,8]. Eighty-
six percent of adolescents with primary hypertension
have a positive family history for hypertension [9].
Breastfeeding is associated with lower blood pressure
levels in childhood [10-12].
Methodology for blood pressure recording in children
and reference values
For correct blood pressure recording it is necessary to
conform the measuring procedure to the method used
for the construction of the reference tables. The children
should be calm and relaxed, seated with their back sup-
ported and their right arm resting at heart level. The cuff
should be of the appropriate size for the children’s upper
arm. Small cuffs tend to overestimate while large cuffs
underestimate. The width of the inflatable cuff should be
40% of the arm circumference at a point midway be-
tween the olecranon and the acromion. A practical way
for estimating the appropriateness of the size is to place
the short segment of the cuff on the central part of the
child’s arm and assure that the arm is encircled by little
less than 50%. In case of doubt it is advised to use the
larger cuff. The cuff bladder length should cover 80% to
100% of the circumference of the arm. The stethoscope
should be placed over the brachial artery pulse, proximal
and medial to the cubital fossa, and below the bottom
edge of the cuff. The bladder should be inflated up to 20
mmHg beyond the disappearance of the radial pulse and
then deflated at a rate of 2–3 mmHg per second. Systolic
blood pressure is defined by the first Korotkoff sound
(K1; appearance of the pulse), whereas diastolic blood
pressure coincides with the disappearance of the pulse
(K5). If Korotkoff sounds do not disappear the muffling
of the sounds (K4) should be considered for diastolic
blood pressure. At least three measurements performed
on different occasions are necessary for the diagnosis of
hypertension. Currently the mercury sphygmomanome-
ters have been proscribed due to their toxicity. The use
of oscillometric devices in children may potentially be a
source of errors. The Internet site www.dableducational.
org reports the oscillometric devices that have been vali-
dated by the scientific societies. A diagnosis of hypertension
based on an oscillometric measurement should be con-














Figure 1 Diagnostic algorithm of hypertension in children and adolescents.
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brated every six months. Children above 3 years of age
should have their blood pressure measured every year on
the occasion of the periodic visits. In all children including
the youngers ones blood pressure should be measured
under special circumstances that increase the risk for
hypertension: intensive neonatal care, renal disease, treat-
ment with drugs known to increase blood pressure, evi-
dence of elevated intracranial pressure.
Almost all the studies on pediatric populations have
used US nomograms for reference. The Recommenda-
tions of the European Society of Hypertension refer to
these tables as well (Tables 2 and 3) [4]. It would be
advisable to consult these nomograms using the North-
American reference values of height percentile. (http://
www.cdc.gov/growthcharts/clinical_charts). It has to be
underlined that the American nomograms have been
obtained by the auscultatory method.
Twenty-hour hour blood pressure monitoring (Ambu-
latory Blood Pressure Monitoring) is validated and used
in adults for the diagnosis of hypertension. It allows to
identify “white coat hypertension” (elevated office blood
pressure values and normal Ambulatory Blood Pressure
Monitoring values) and “masked hypertension” (normal
office blood pressure values and elevated Ambulatory
Blood Pressure Monitoring values). This technique can
also identify subjects with or without reduced physio-
logical day-night blood pressure variations. In children
the use of Ambulatory Blood Pressure Monitoring has
significant limitations due to the lack of reference values
that have been validated in sufficiently large populations.
The only existing nomograms (recommended both bythe American Heart Association and the European Soci-
ety of Hypertension) refer to a study that is based on a
relatively small number of subjects. The study provides
the values corresponding to the 75th, 90th e 95th percent-
ile of the mean daytime and nighttime blood pressure by
gender and in accordance with age and height, displayed
separately however (Tables 4 and 5) [13].
A new and important chapter in blood pressure
monitoring is the self-measurement of blood pres-
sure at home. Even in this case available data from
children are scanty. In any way reference values have
been suggested derived from a study on about 800
subjects. Correct self-measurement requires two
measurements within a few minutes, performed in
the morning and in the evening for 3 consecutive
days (Table 6) [14].
Monitoring of organ damage
Hypertension is one of the main risk factors for the de-
velopment of cardiac, cerebrovascular and renal diseases.
It represents an important pathophysiological substrate
for the development of atherosclerosis and consequent
organ damage. Once hypertension has been diagnosed it
is important to determine the presence of organ damage
for the stratification of cardiovascular risk. Major atten-
tion should be paid to heart, arteries, kidney, nervous
system and retina.
Heart and vessels
Left ventricular hypertrophy which is associated with
cardiac disease and mortality in adults is the organ dam-
age that has been most documented in hypertensive
Table 2 Blood pressure percentiles for boys by age and height
Systolic (mmHg) percentile of height Diastolic (mmHg) percentile of height
Age (years) BP percentile 5th 10th 25th 50th 75th 90th 95th 5th 10th 25th 50th 75th 90th 95th
1 90th 94 95 97 99 100 102 103 49 50 51 52 53 53 54
95th 98 99 101 103 104 106 106 54 54 55 56 57 58 58
99th 105 106 108 110 112 113 114 61 62 63 64 65 66 66
2 90th 97 99 100 102 104 105 106 54 55 56 57 58 58 59
95th 101 102 104 106 108 109 110 59 59 60 61 62 63 63
99th 109 110 111 113 115 117 117 66 67 68 69 70 71 71
3 90th 100 101 103 105 107 108 109 59 59 60 61 62 63 63
95th 104 105 107 109 110 112 113 63 63 64 65 66 67 67
99th 111 112 114 116 118 119 120 71 71 72 73 74 75 75
4 90th 102 103 105 107 109 110 111 62 63 64 65 66 66 67
95th 106 107 109 111 112 114 115 66 67 68 69 70 71 71
99th 113 114 116 118 120 121 122 74 75 76 77 78 78 79
5 90th 104 105 106 108 110 111 112 65 66 67 68 69 69 70
95th 108 109 110 112 114 115 116 69 70 71 72 73 74 74
99th 115 116 118 120 121 123 123 77 78 79 80 81 81 82
6 90th 105 106 108 110 111 113 113 68 68 69 70 71 72 72
95th 109 110 112 114 115 117 117 72 72 73 74 75 76 76
99th 116 117 119 121 123 124 125 80 80 81 82 83 84 84
7 90th 106 107 109 111 113 114 115 70 70 71 72 73 74 74
95th 110 111 113 115 117 118 119 74 74 75 76 77 78 78
99th 117 118 120 122 124 125 126 82 82 83 84 85 86 86
8 90th 107 109 110 112 114 115 116 71 72 72 73 74 75 76
95th 111 112 114 116 118 119 120 75 76 77 78 79 79 80
99th 119 120 122 123 125 127 127 83 84 85 86 87 87 88
9 90th 109 110 112 114 115 117 118 72 73 74 75 76 76 77
95th 113 114 116 118 119 121 121 76 77 78 79 80 81 81
99th 120 121 123 125 127 128 129 84 85 86 87 88 88 89
10 90th 111 112 114 115 117 119 119 73 73 74 75 76 77 78
95th 115 116 117 119 121 122 123 77 78 79 80 81 81 82
99th 122 123 125 127 128 130 130 85 86 86 88 88 89 90
11 90th 113 114 115 117 119 120 121 74 74 75 76 77 78 78
95th 117 118 119 121 123 124 125 78 78 79 80 81 82 82
99th 124 125 127 129 130 132 132 86 86 87 88 89 90 90
12 90th 115 116 118 120 121 123 123 74 75 75 76 77 78 79
95th 119 120 122 123 125 127 127 78 79 80 81 82 82 83
99th 126 127 129 131 133 134 135 86 87 88 89 90 90 91
13 90th 117 118 120 122 124 125 126 75 75 76 77 78 79 79
95th 121 122 124 126 128 129 130 79 79 80 81 82 83 83
99th 128 130 131 133 135 136 137 87 87 88 89 90 91 91
14 90th 120 121 123 125 126 128 128 75 76 77 78 79 79 80
95th 124 125 127 128 130 132 132 80 80 81 82 83 84 84
99th 131 132 134 136 138 139 140 87 88 89 90 91 92 92
15 90th 122 124 125 127 129 130 131 76 77 78 79 80 80 81
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Table 2 Blood pressure percentiles for boys by age and height (Continued)
95th 126 127 129 131 133 134 135 81 81 82 83 84 85 85
99th 134 135 136 138 140 142 142 88 89 90 91 92 93 93
16 90th 125 126 128 130 131 133 134 78 78 79 80 81 82 82
95th 129 130 132 134 135 137 137 82 83 83 84 85 86 87
99th 136 137 139 141 143 144 145 90 90 91 92 93 94 94
17 90th 127 128 130 132 134 135 136 80 80 81 82 83 84 84
95th 12 132 134 136 138 139 140 84 85 86 87 87 88 89
99th 139 140 141 143 145 146 147 92 93 93 94 95 96 97
4° Report on the Diagnosis, Evaluation and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics 2004 [4].
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the relationship between childhood hypertension and
adult cardiovascular risk [15,16]. It has however been
demonstrated that in children both physiological and
pathological increases in blood pressure progressively
modify the geometry of the left ventricle causing a
significant increase in its wall thicknesses [17,18] and
that cardiac mass is already subject to change during the
early hypertensive stages [19] and associated with 24h
systolic blood pressure [20]. Both the rate of development
and the rate of regression of left ventricular hypertrophy
are inversely correlated with age [21]. In hypertensive
subjects with left ventricular hypertrophy normalization of
blood pressure determines a echocardiographically detect-
able normalization of ventricle mass and functional
parameters, but cardiovascular risk still remains elevated
compared to normotensive subjects [22]. Therefore it is im-
portant to identify subjects with hypertension before left
ventricular hypertrophy develops. In children the complex
relationship between growth of the heart and of the body
as a whole complicates the indexation of cardiac mass, es-
pecially in the lowest age ranges. Various methods for
indexation have been proposed for pediatric patients. Ven-
tricular mass can be calculated echocardiographically using
the Devereux equation [23] indexed for body surface area
during infancy or for weight only in newborns, whereas
indexation for height should be preferred from 8–9 years
onwards [16]. The majority of published studies define a
cut-off value of ≥ 38.6 g/m2.7 for the presence of ventricular
hypertrophy in childhood [24]. Recently reference centiles
for left ventricular mass/m2.7 have been proposed that have
been derived from 2273 normal weight subjects aged be-
tween 0 and 18 years [25].
Many data have been published concerning early arter-
ial lesions in hypertensive children. The most precocious
change of the arterial wall that can be shown by ultra-
sound techniques is thickening of the intima-media
layers [26-30]. In the general pediatric population the
intima-media thickness increases with age and is related
to blood pressure [31]. Intima-media thickening de-
velops in parallel with the development of leftventricular hypertrophy [26]. A prolonged exposure to
increased blood pressure or to metabolic alterations may
cause irreversible remodeling of the arterial walls. For
this reason therapeutic interventions should be intro-
duced as soon as possible in order to achieve regression
of the vascular alterations as long as this is still achiev-
able. It has been demonstrated that in hypertensive chil-
dren the reduction of blood pressure values causes a
regression of the carotid intima-media thickness [32].
The clinical relevance of intima-media thickness seems
similar to that of echocardiographic measurement of left
ventricular mass and the measurement of intima-media
thickness could be used for the evaluation of organ dam-
age and for the monitoring of the disease and its treat-
ment. However such measurements should be
standardized in order to avoid errors due to the use of dif-
ferent methods.
Kidney
The kidney plays a central role in the development of
many forms of hypertension. For this reason it is often
difficult to determine the cause-effect relationship be-
tween increases in blood pressure and renal abnormal-
ities. The prevalence of end-stage renal disease due to
hypertension in adults is a well-known and worsening
phenomenon. It is not entirely clear however to what
extent rises in blood pressure contribute to the progres-
sion of renal alterations towards end-stage renal disease.
Generally children and adolescents do not develop clinically
evident renal abnormalities in response to increases in
blood pressure. So the important question if there are any
renal alterations in children with mild-moderate hyperten-
sion remains to be answered. The observation of contem-
poraneous hypertension and reduced glomerular filtration
rate in children probably suggests the presence of a second-
ary form of hypertension. This also holds for the presence
of proteinuria (>300 mg/day). The matter is more complex
concerning microalbuminuria (30–300 mg/day, 2–30 mg/
mmol urinary creatinine, 20–200 μg/min); in adult hyper-
tension microalbuminuria is a consolidated marker of car-
diovascular risk, whereas in children more studies would be
Table 3 Blood pressure percentiles for girls by age and height
Systolic (mmHg0 percentile of height Diastolic (mmHg) percentile of height
Age (years) BP percentile 5th 10th 25th 50th 75th 90th 95th 5th 10th 25th 50th 75th 90th 95th
1 90th 97 97 98 100 101 102 103 52 53 53 54 55 55 56
95th 100 101 102 104 105 106 107 56 57 57 58 59 59 60
99th 108 108 109 111 112 113 114 64 64 65 65 66 67 67
2 90th 98 99 100 101 103 104 105 57 58 58 59 60 61 61
95th 102 103 104 105 107 108 109 64 62 62 63 64 65 65
99th 109 110 111 112 114 115 116 69 69 70 70 71 72 72
3 90th 100 100 102 103 104 106 106 61 62 62 63 64 64 65
95th 104 104 105 107 108 109 110 65 66 66 67 68 68 69
99th 111 111 113 114 115 116 117 73 73 74 74 75 76 76
4 90th 101 102 103 104 106 107 108 64 64 65 66 67 67 68
95th 105 106 107 108 110 111 112 68 68 69 70 71 71 72
99th 112 113 114 115 117 118 119 76 76 76 77 78 79 79
5 90th 103 103 105 106 107 109 109 66 67 67 68 69 69 70
95th 107 107 108 110 111 112 113 70 71 71 72 73 73 74
99th 114 114 116 117 118 120 120 78 78 79 79 80 81 81
6 90th 104 105 106 108 109 110 111 68 68 69 70 70 71 72
95th 108 109 110 111 113 114 115 72 72 73 74 74 75 76
99th 115 116 117 119 120 121 122 80 80 80 81 82 83 83
7 90th 106 107 108 109 111 112 113 69 70 70 71 72 72 73
95th 110 111 112 113 115 116 116 73 74 74 75 76 76 77
99th 117 118 119 120 122 123 124 81 81 82 82 83 84 84
8 90th 108 109 110 111 113 114 114 71 71 71 72 73 74 74
95th 112 112 114 115 116 118 118 75 75 75 76 77 78 78
99th 119 120 121 122 123 125 125 82 82 83 83 84 85 86
9 90th 110 110 112 113 114 116 116 72 72 72 73 74 75 75
95th 114 114 115 117 118 119 120 76 76 76 77 78 79 79
99th 121 121 123 124 125 127 127 83 83 84 84 85 86 87
10 90th 112 112 114 115 116 118 118 73 73 73 74 75 76 76
95th 116 116 117 119 120 121 122 77 77 77 78 79 80 80
99th 123 123 125 126 127 129 129 84 84 85 86 86 87 88
11 90th 114 114 116 117 118 119 120 74 74 74 75 76 77 77
95th 118 118 119 121 122 123 124 78 78 78 79 80 81 81
99th 125 125 126 128 129 130 131 85 85 86 87 87 88 89
12 90th 116 116 117 119 120 121 122 75 758 75 76 77 78 78
95th 119 120 121 123 124 125 126 79 79 79 80 81 82 82
99th 127 127 128 130 131 132 133 86 86 87 88 88 89 90
13 90th 117 118 119 121 122 123 124 76 76 76 77 78 79 79
95th 121 122 123 124 126 127 128 80 80 80 81 82 83 83
99th 128 129 130 132 133 134 135 87 87 88 89 89 90 91
14 90th 119 120 121 122 124 125 125 77 77 77 78 79 80 80
95th 123 123 125 126 127 129 129 81 81 81 82 83 84 84
99th 130 131 132 133 135 136 136 88 88 89 90 90 91 92
15 90th 120 121 122 123 125 126 127 78 78 78 79 80 81 81
Spagnolo et al. Italian Journal of Pediatrics 2013, 39:20 Page 6 of 18
http://www.ijponline.net/content/39/1/20
Table 3 Blood pressure percentiles for girls by age and height (Continued)
95th 124 125 126 127 129 130 131 82 82 82 83 84 85 85
99th 131 132 133 134 136 137 138 89 89 90 91 91 92 93
16 90th 121 122 123 124 126 127 128 78 78 79 80 81 81 82
95th 125 126 127 128 130 131 132 82 82 83 84 85 85 86
99th 132 133 134 135 137 138 139 90 90 90 91 92 93 93
17 90th 122 122 123 125 126 127 128 78 79 79 80 81 81 82
95th 125 126 127 129 130 131 132 82 83 83 84 85 85 86
99th 133 133 134 136 137 138 139 90 90 91 91 92 93 93
4° Report on the Diagnosis, Evaluation and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics 2004 [4].
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vated blood pressure values. In pediatric subjects with
chronic kidney disease it has been shown that high blood
pressure and proteinuria are the two main predictive factors
for progression to chronic renal failure [33]. To verify the
renoprotective effect of antihypertensive treatment in chil-
dren with chronic renal failure a European randomized
multicenter trial has shown that in subjects with lower BP
target (<50th percentile) progression of renal failure was de-
layed more compared to subjects with higher BP target
(50th-90th percentile) [34].
Nervous system
A reduction in baroreflex sensitivity has been shown in
children with hypertension and high-normal blood pres-
sure when compared to normotensive children [35].
While acknowledging that convulsions and cerebrovas-
cular accidents in children may represent complications
of some forms of severe or malignant hypertension,
these complications are practically nonexistent in the





75th 90th 95th 75th 90th 95t
5 116/76 120/79 123/81 99/59 103/62 106/
6 116/76 121/79 124/81 100/59 105/63 108/
7 117/76 122/80 125/82 101/60 106/64 110/
8 117/76 122/80 125/82 102/60 108/64 111/
9 118/76 123/80 126/82 103/60 109/64 112/
10 119/76 124/80 127/82 104/60 110/64 113/
11 121/76 126/80 129/82 105/60 111/64 115/
12 123/76 128/80 132/82 107/60 113/64 116/
13 126/76 131/80 1365/82 109/60 115/64 119/
14 129/77 134/80 138/82 112/61 118/64 121/
15 132/77 137/81 141/83 114/61 120/64 123/
16 135/78 140/81 144/84 117/61 123/64 126/
Wühl E et al., German Working Group on Pediatric Hypertension. “Distribution of 24
of body dimensions”. J Hypertens 2002; 20:1995–2007 [13].Retina
Currently there are few data in literature regarding the
effect of blood pressure on the retinal circulation in chil-
dren. Fifty-one percent of hypertensive children are sup-
posed to have retinal alterations that can be detected by
direct ophthalmoscopy [36]. It has been revealed that in
non-hypertensive children between 6 and 8 years of age
each 10 mmHg increment in systolic blood pressure was
associated with a reduction of the retinal arteriolar
caliber of 1.43-2.08 micron, measured by quantitative
analysis of the digital photographs of the retina [37] .
Hypertensive emergencies
Hypertensive emergencies are defined as situations in
which increases in blood pressure are accompanied by
acute symptoms of organ damage: hypertensive enceph-
alopathy (convulsions, cerebrovascular accidents) and
congestive heart failure which expose the patients to
life-threatening risks or to severe complications within
minutes or hours. Hypertensive emergencies require
immediate pharmacological treatment, while bearing inby age and gender
Girls
Day Night
h 75th 90th 95th 75th 90th 95th
65 114/77 118/80 121/82 100/81 105/66 108/69
66 155/77 120/80 122/82 101/61 106/65 110/68
67 116/77 121/80 123/82 102/60 107/65 111/67
67 117/76 122/80 124/82 103/60 108/64 112/67
67 118/76 122/80 125/82 103/59 109/64 112/6
67 119/76 123/79 126/81 104/59 110/64 113/67
67 120/76 120/79 127/81 105/59 110/63 114/66
67 121/76 125/80 128/82 105/59 110/63 114/66
67 122/77 126/80 129/82 106/59 111/63 114/66
67 123/77 127/80 130/82 106/59 111/63 114/65
66 124/77 128/80 130/82 107/59 111/63 114/65
66 124/77 129/77 131/82 107/59 111/63 114/65
-h ambulatory blood pressure in children: normalized reference values and role




Day Night Day Night
75th 90th 95th 75th 90th 95th 75th 90th 95th 75th 90th 95th
120 116/77 111/80 125/82 99/58 103/61 106/63 114/77 118/80 120/82 99/60 103/63 106/65
125 117/76 122/80 125/82 100/58 105/61 108/63 115/77 119/80 121/82 100/60 104/63 107/66
130 117/76 122/80 126/82 101/59 106/62 110/64 116/76 120/80 122/82 101/59 106/63 108/66
135 117/76 123/80 126/82 102/59 108/63 111/65 116/76 120/80 123/82 102/59 107/63 109/66
140 118/76 123/80 126/82 104/60 109/63 113/65 117/76 121/80 124/82 103/59 108/63 110/66
145 119/76 124/79 127/81 105/60 111/64 144/66 11876 123/80 125/82 103/59 109/63 112/66
150 120/76 125/79 128/81 106/60 112/64 116/66 119/76 124/80 127/82 104/59 110/63 113/66
155 122/76 127/79 130/81 107/60 113/64 117/66 121/76 125/80 128/82 106/59 111/63 114/66
160 124/76 129/79 133/81 108/60 144/64 188/66 122/76 126/80 129/82 106/59 111/63 114/66
165 126/76 132/80 135/82 110/60 116/64 119/66 123/77 127/80 130/82 107/59 112/63 114/66
170 128/77 134/80 138/82 112/61 117/64 121/66 124/77 128/80 131/82 108/61 112/67 115/71
175 130/77 136/81 140/83 113/61 119/64 112/66 125/78 129/81 131/82 109/59 113/63 115/66
180 132/77 138/81 142/83 115/61 120/64 124/66 N/A N/A N/A N/A N/A N/A
185 134/78 140/81 144/84 116/61 122/64 125/66 N/A N/A N/A N/A N/A N/A
Wühl E et al., German Working Group on Pediatric Hypertension. “Distribution of 24-h ambulatory blood pressure in children: normalized reference values and role
of body dimensions”. J Hypertens 2002; 20:1995–2007 [3].
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abrupt. For this reason marked increases in blood pres-
sure without symptoms of hypertensive encephalopathy
or acute heart failure should be preferably treated with
oral agents. As in children this condition is always due
to secondary forms of hypertension specific tests should
be performed [38-41].
The role of the Family Pediatrician
The Italian Health System guarantees the assistance of
the vast majority of children by a Family Pediatrician.
This resource should allow the activation of prevention
strategies for the most important chronic and degenera-
tive diseases, starting immediately at young ages. Among





N 50th 95th N 50th 95th
120-129 23 105/64 119/76 36 101/64 119/74
130-139 51 108/64 101/77 51 103/64 120/76
140-149 39 110/65 125/77 61 105/65 122/77
150-159 41 112/65 126/78 71 108/66 123/77
160-169 45 115/65 123/78 148 110/66 124/78
170-179 91 117/66 132/78 46 112/66 125/79
180-189 57 121/67 134/79 7 114/67 128/80
Stergiou GS et al. “Home blood pressure normalcy in children and adolescents:
the Arsakeion School study”. J Hypertens 2007; 25:1375–1379 [14].its high prevalence, especially when combined to over-
weight. For this reason the physician who follows chil-
dren during the developmental age should:
 Collect an accurate family history to identify
primary and secondary forms of hypertension.
 Use standardized methods and suitable instruments
for a correct measurement of blood pressure in the
child and interpret the values according to the most
extensive and updated tables.
 Monitor blood pressure during annual control visits
from the age of three.
 Repeat the blood pressure measurement on at least
three different occasions when values are observed
that could indicate hypertension or high normal
blood pressure.
 Learn to make a first differential diagnosis between
primary and secondary forms of hypertension on the
basis of clinical history, physical examination,
targeted examinations.
 Send patients with suspect secondary hypertension
to referral centers.
 Apply the principles of the dietary and behavioral
interventions in the treatment of the primary forms.
 Send patients with suspect secondary hypertension
and cases of primary hypertension who do not
respond to dietary and behavioral therapy to
specialist centers.
 Cooperate with the specialist centers in the follow-
up of the hypertensive child.
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identified a prevalence of 4% of children with high blood
pressure [42], but the number of specialist centers for
pediatric hypertension is limited. So it would be advis-
able to increase the availability and accessibility of these
centers, but also to improve the expertise of the pediatri-
cians in the management of subjects with high normal
blood pressure or with non severe essential hypertension.
For children with high normal blood pressure values it is
sufficient to implement dietary and behavioral therapy and
perform period blood pressure controls. For subjects with
confirmed values above or equal to the 95th percentile,
there should be a distinction between those who have
values above the 99th percentile and those who do not
present such high values (95-99th percentile). In the first
case it is suitable to send the patient to a specialist center
because of the high probability of secondary hypertension,
whereas in the second case the presence of peripheral
pulses and negative results of simple diagnostic tests (blood
sodium, potassium, creatinine, thyroid hormones, urine
test) would direct towards the diagnosis of essential hyper-
tension. In the latter condition, the Family Pediatrician can
start dietary-behavioral therapy and send the child to a spe-
cialist center if no satisfactory improvement in blood pres-
sure values is achieved. Once hypertension has beenBP measurement during annual control vis
Mean of 3 BP measurements on dif
SBP and DBP 
< 90th p
Check BP during 
annual visits
SBP and/or DBP 
 90th and < 95th p
High normal BP
 Overweight when present















Figure 2 Flow chart for diagnosis and management of hypertension idiagnosed it is advisable to search for other cardiovascular
risk factors, such as total and HDL cholesterol, triglycer-
ides, fasting glycemia and insulinemia. Figure 2 reports the
algorithm that is suggested when elevated blood pressure
values are found in children and adolescents. The hyperten-
sive child and its parents should be followed with frequent
control visits, because it is not easy to maintain treatment
compliance in a disease that does not entail subjective
disturbances. It would be desirable that in the future the
network of Family Pediatricians may collaborate in the col-
lection of epidemiological data on hypertension in the de-
velopmental age.
Role of specialist centers
The specialist centers have the duty to guarantee a multi-
disciplinary approach to the hypertension problem in chil-
dren. They should provide pediatric, cardiologic,
nephrologic, endocrinologic, dietary and in some cases psy-
chological expertise. These centers should obtain ample ex-
perience in the evaluation of organ damage, interpretation
of 24 hour ambulatory blood pressure monitoring and self-
measurement of blood pressure at home. They should also
have access to laboratory techniques and instruments ne-
cessary for the diagnosis of different forms of secondary
hypertension. It is important that the specialist centersit: BP > 90th percentile
ferent occasions
SBP and/or DBP 
























n children and adolescents.
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family doctors with the aim of outlining the therapy and
monitoring the hypertensive child.
Prevention of hypertension in children and adolescents
Prevention should aim at avoiding the onset of hyper-
tension both in children and in adults. Therefore the
pediatrician should identify the main risk factors:
 Family history of hypertension
A lot of international studies show that children com-
ing from hypertensive families have a greater risk to
present with elevated blood pressure values [7,8].
 Low birth weight
Epidemiological studies have shown that intrauterine
growth delay and low birth weight are risk factors for
hypertension and cardiovascular diseases in adulthood
[43,44]. A large meta-analysis on 55 studies has revealed
an inverse relationship between birth weight and blood
pressure values [45]. The hypothesis of a fetal origin of
diseases that become manifest in adult age suggests that
environmental factors and prenatal nutritional factors in
particular act during the early phases of life predisposing
to metabolic and cardiovascular diseases [46]. Experi-
mental studies demonstrate that placental insufficiency
modifies myocardiocyte and coronary maturation of the
fetus [47]. Ultrasound studies performed in pregnant
women show that intrauterine growth delay induces
alterations in the fetal cardiovascular system [48,49].
The relationship between poor intrauterine growth and
hypertension may be explained by different mechanisms
such as development of a lower number of nephrons,
excessive exposure to glucocorticoids, changes in the
regulation of the renin-angiotensin-aldosterone system
and early development of insulin resistance [46]. Rapid
postnatal weight recovery and overweight in later years
may play an important role in these subjects [50]. As
there are no specific therapies available than can modify
the effects initiated during intrauterine life, the only
remaining treatment is prevention. The inverse relation-
ship between birth weight and blood pressure becomes
more marked with increasing age. Children with low
birth weight should have their blood pressure monitored
throughout childhood. Special attention should be paid
to their nutrition program by promoting breastfeeding
and recommending weaning and nutrition programs that
avoid excessively rapid or intense weight gain. More than
other children these subjects should be recommended to
limit salt intake and to increase their physical activity.
 Overweight and obesityOverweight represents over 50% of all the causes of
hypertension in children [51]. The relationship between
BMI and blood pressure values has been extensively docu-
mented. Recently a correlation with other markers of
obesity, particularly abdominal obesity, has been found [52].
 Sedentary behavior
Adequate physical activity lasting 40 minutes for 3–5
times a week causes a reduction in blood pressure values
[51,53]. A dual intervention on both diet and physical
activity contributes even more to blood pressure reduc-
tion in children [54].
 Substances that increase blood pressure
Salt rich diets already affect blood pressure in child-
hood [55], while potassium supplementations could
reduce blood pressure values [56].
Some drugs increase blood pressure (steroids, erythro-
poietin, theophylline, beta-stimulants, cyclosporine, ta-
crolimus, tricyclic antidepressants, antipsychotics, nasal
decongestionants, oral contraceptives). Alcohol and ex-
cessive licorice consumption may increase blood pres-
sure. Some psychoactive drugs and particularly cocaine
and amphetamines raise blood pressure as well.
 Cigarette smoke
Infants whose mothers smoked during pregnancy
have higher blood pressure than babies born from
non-smoking mothers [57] and they show an increased
hypertensive response to stress compared to peers up
to the age of one year [58]. Exposure to passive smok-
ing as well seems to play a role in increasing blood
pressure [59,60].
 Non sustained form of hypertension
The finding of elevated blood pressure values at a
control visit that is not confirmed at subsequent mea-
surements could represent a risk factor for later develop-
ment of hypertension [61]. A recent study reports that
subjects with elevated blood pressure values at in the
doctor’s office and normal range values at 24 hour am-
bulatory blood pressure monitoring presented greater
cardiac masses than normotensives of the same age [62].
Table 7 summarizes the information that should be
collected in the case of high blood pressure findings in
children or adolescents.
Newborn hypertension
The first blood pressure measurements in newborns
with reliable techniques go back to the 1970’s. In those
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values in 6.000 Italian full-term newborns between 43.1
mmHg on the first day and 62.0 mmHg after 6 days of
life using ultrasound techniques [63]. Generally in pre-
term newborns values are about 10 mmHg lower. The
recent availability of oscillometric devices opens new
study possibilities. From the data in literature it can be
affirmed that based on both Doppler and oscillometric
evaluations a diagnosis of neonatal hypertension can be
made in full-term newborns when observing systolic
blood pressure values that are permanently higher than
90 mmHg [64]. Correct recordings of the blood pressure
in newborns require cuffs that have appropriate length
(at least 3/2 the circumference of the arm) and width
(about 2/3 the length of the arm). As a rule the cuff size
used in preterm babies is 2.5 cm, in full-term newborns
4 cm, and 6–8 cm in 1 month old babies [65]. In order
to obtain correct blood pressure recordings the new-
born/baby should be calm and supine and the mean of 3
measurements should be considered. The prevalence of
neonatal hypertension has been estimated between 0.2
and 3% in the newborn population as whole, whereas in
preterm and full-term infants cared for in neonatal in-
tensive care units hypertension is observed in more than
2% of the subjects. These data should be confirmed by
systematic measurements in all birth centers andTable 7 Medical history to record in children and adolescents
Family history
• Hypertension




• Hereditary renal disease (Polycystic kidney disease)
• Hereditary endocrine disease (pheochromocytoma, adren
• Syndromes associated with hypertension (neurofibromato
Clinical history
• Perinatal history: birth weight, gestational age, oligohyd
• Previous history: urinary tract infection, renal or urologic
growth retardation
• Symptoms suggestive of secondary hypertension: dys
thrive, palpitations, sweating, fever, pallor, flushing, cold e
male pseudohermaphroditism
• Symptoms suggestive of target organ damage: heada
• Sleep history: snoring, apnea, daytime somnolence
• Risk factor history: low physical exercise level, incorrect
• Drug intake: cyclosporine, tacrolimus, tricyclic anti-depres
• Pregnancy
Lurbe et al. “Management of High Blood Pressure in Children and Adolescents: recohospitals and the blood pressure values should be
reported in the hospital discharge papers. Hypertension
in newborns and infants is almost exclusively seen in the
secondary form. The main causes involve either the re-
novascular system with vascular stenosis or thrombosis,
the cardiovascular system with aortic coarctation, or the
intrinsic renal forms (hydronephrosis, polycystic kidney,
hypoplastic kidney, Wilms tumor and pyelonephritis)
and the endocrine forms (neuroblastoma, adrenogenital
syndrome and pheochromocytoma) [66]. Umbilical ar-
tery catheterization with consequent thromboembolism
of the aorta and/or the renal arteries is one of the most
typical iatrogenic causes in the neonatal intensive care
units. The hypertensive newborn may present irritability,
seizures, respiratory disturbances and acute heart failure.
First-line laboratory test are: urine test, serum ionogram,
blood count, blood urea nitrogen and creatinine.
Catecholamine and urinary 17-ketosteroid dosing may
be useful. Diagnostic imaging may involve echography,
urography and even aortography when necessary. For
the prevention of hypertension breastfeeding should be
promoted which should be exclusive during the first 6
months and maintained up to 1 year [67]. If breast milk
is not available it is advised to use low sodium and low
protein formulations. During weaning no salt should be
added to the baby food.with hypertension
al hyperplasia, multiple endocrine neoplasia , von Hippel-Lindau)
sis)
ramnios, anoxia, umbilical artery catheterization
al disease, cardiac, endocrine (including diabetes) or neurological disease,
uria, thirst/polyuria, nocturia, hematuria, edema, weight loss, failure to
xtremities, intermittent claudication, virilization, primary amenorrhea,
che, epistaxis, vertigo, visual impairment, facial palsy, fits, strokes, dyspnea
dietary habits, smoking, alcohol, licorice
sants, antipsychotics, decongestants, oral contraceptives, illegal drugs
mmendations of the ESH”. Journal of Hypertension 2009 [2] (modified).
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Hypertension is defined secondary when causes can be
found that can be treated with specific interventions. The
causes of hypertension vary according to different periods
in childhood. Secondary hypertension is more frequent dur-
ing the first years of life whereas the prevalence of essential
hypertension increases with age. The attention that has to
be given in finding secondary causes of hypertension should
be inversely proportional to age and directly proportional
to the severity of the hypertension. The evaluation of chil-
dren with hypertension should always be aimed at exclud-
ing secondary forms. In children hypertension due to renal
causes (chronic kidney disease or renovascular hyperten-
sion) and aortic coarctation accounts for 70 to 90% of
the secondary forms [68,69]. Endocrinologic (Primary
hyperaldosteronism, Cushing's syndrome, Adrenogenital
syndrome, Hyperthyroidism, Pheochromocytoma) and
other causes (drug-induced and genetic forms) are more
uncommon. The assessment of a hypertensive child
should consider blood pressure values, age, clinical signs
and family history. Table 8 shows the guiding criteria
for the distinction between essential and secondary
forms of hypertension. A detailed description of the
diagnostic processes of secondary forms of hyperten-
sion [70-72] goes beyond the goals of the present
recommendations.
Dietary-behavioral interventions
Dietary-behavioral therapy is indicated in children with
hypertension or high-normal blood pressure and should be
advised to those with transiently elevated blood pressure
values or with positive family history for hypertension. This
therapy should be maintained even if pharmacological
treatment is adopted as well [73-75]. Non-pharmacologicalTable 8 Guiding criteria for the differential diagnosis betwee
hypertension
Essential forms
Onset Most frequent in childre
adolescents
Discovery Casual during annual co
Blood pressure values Moderately elevated
Associated symptoms None




Difference between BP values in upper and lower
extremities
Not present
Blood sodium, potassium and creatinine levels,
urinalysis, thyroid hormones
Normal
Echocardiography Normal (left ventricular
hypertrophy may be pretreatment of hypertension is based on correct lifestyle and
nutrition; participation of the parents in the acceptance and
execution of the treatment is important for increasing the
adhesion to the program. Dietary-behavioral therapy is
based on the following points:
 Reduction of overweight
As increased blood pressure is often associated with over-
weight [5,76,77], weight reduction can reduce blood pres-
sure levels. Regarding the definition of overweight and
obesity in childhood the criteria proposed by Cole in 2000
[78] need to mentioned; these criteria have been adopted
by the International Obesity Task Force and use body mass
index (BMI = weight in kg/height2 in m) depending on age
and gender. Goals of the treatment are: maintaining a nor-
mal height-weight growth in normal weight children; trying
to improve BMI by a greater increase in height compared
to weight in overweight subjects up to 8 years of age; pur-
suing gradual weight loss in older children and adolescents
with excess weight. In obese hypertensive subjects the aim
is achieving weight loss, 1–2 kg a month in adolescents,
through the adoption of a moderately hypocaloric diet. In
all cases varied dietary schedules are advised which include
all food groups and offer a correct division of the meals
(15% breakfast, 5% snack, 40% lunch, 10% snack, 30%
dinner), having the best possible distribution of cal-
oric (proteins 10-12%, lipids 28-30%, carbohydrates
60%) and non-caloric nutrients (vitamins, minerals,
oligoelements, fibers) according to the indications by
LARN [79] and observing the nutritional needs of
growing individuals [80]. In the case of severe obes-
ity (BMI > 99th percentile according to the parame-
ters of the American Academy of Pediatrics [81]),n essential hypertension and secondary forms of
Secondary forms
n and Often early
ntrol visit Often underlying disease already known
Often markedly elevated
According to specific disorder
ial Familiar forms are rare
Not frequent
Reduced or absent with coarctation of the aorta
Present with coarctation of the aorta
Altered in some specific disorders
sent)
Allows diagnosis of coarctation of the aorta (left ventricular
hypertrophy may be present)
Table 9 Lifestyle and dietary recommendations to reduce high blood pressure values
Goals
• BMI in the normal weight range: maintain BMI to prevent overweight
• BMI in the overweight range: weight maintenance in younger children or gradual weight loss in older children and
adolescents to return to the normal weight range
• BMI in the obesity range: gradual weight loss (1–2 kg/month) to achieve normal weight
General recommendations
• Moderate to vigorous physical aerobic activity for 40 min, 3–5 days/week and avoid more than 2 h of daily sedentary
activities (besides school hours)
• Participation in (competitive) sports activities limited only in the presence of uncontrolled stage 2 hypertension
• Avoid severe dietary restrictions, reduce portion size, stimulate the habit of having breakfast
• Limit salt intake
• Avoid intake of excess sugar, excess soft drinks, saturated and trans fat, animal protein
• Drink water
• Stimulate the intake of healthy food (fruit, vegetables, legumes, whole grain products, fish)
• Implement the behavioral changes (physical activity and diet) suitable for individual and family characteristics
• Establish realistic goals
• Involve the family, caregivers, teachers and other educators in the process of dietary and life-style changes
• Provide educational support and materials
• Develop reward systems (non-food) to achieve healthy behavior
Lurbe et al. “Management of High Blood Pressure in Children and Adolescents: recommendations of the ESH”. Journal of Hypertension 2009 [2] (modified).
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vidualized by an integrated multidisciplinary team.
 Reduction of salt intake
Trials on the relationship between sodium intake and
blood pressure in children are limited. In adults it has been
demonstrated that moderate salt intake restriction reduces
blood pressure in sodium-sensitive subjects, i.e. 50-60% of
all hypertensives [55]. A meta-analysis has shown that a
modest reduction in sodium intake in children causes
a decrease in blood pressure values and may deter-
mine a reduction of the physiological age-related in-
crease in blood pressure [82]. Currently only few data
are available on sodium intake in young generations.
The rise in use of precooked foods and outdoor eating
may have increased salt intake compared to the past. Diet-
ary salt can be divided in discretionary salt which is kit-
chen salt added during and after cooking and at the table
(about 36%) and non-discretionary salt. Non-discretionary
salt includes the salt that is present in the food itself
(about 10%) and the salt that has been added for preserva-
tion and increasing taste of the food (remaining 54%) [83].
People have an innate tendency to appreciate salty flavor
but the amount of salt needed by every single person de-
pends on the dietary habits learned during childhood. In
order to limit sodium intake it is advised to eat almost ex-
clusively fresh food and to cook it without salt thus redu-
cing the use of NaCl to a level teaspoon full equaling 5 g
of salt or approximately 2 g of sodium. In this way dailyintake can be limited to about 2.5 g or even less after fur-
ther discretionary salt reduction. It would be advisable to
use unsalted bread, like Tuscan bread. The consumption
of fruit and vegetables is particularly recommended in
hypertension as, besides limiting caloric intake and favor-
ing sufficient amounts of vitamins and micronutrients, it
also increases the intake of potassium which is believed to
have a positive effect on blood pressure [56]. Sufficient
calcium intake is recommended that can be obtained by
consumption of nonfat milk and dairy products.
 Increase in physical activity
Forty minutes of aerobic-based physical activity 3–5
days/week are required to improve cardiovascular func-
tion and reduce blood pressure in children [51]. It is also
necessary to avoid more than 2 h daily of sedentary ac-
tivities [2]. Regular sport practice should be encouraged
(excluding particularly competitive activities in children
with stage 2 hypertension that cannot be controlled with
pharmacological therapy) as well as unstructured phys-
ical activity [74,84] such as walking to school, taking a
walk, riding a bike, playing. Outdoor activities should be
stimulated, whereas time spent in sedentary activities
such as watching TV, playing videogames, suing the
computer should be limited [85]. A research by the Ital-
ian Society of Pediatrics shows that 60% of 12–14 year
old children spend 1–3 hours a day watching TV and
20% even exceed 3 hours [86]. Fifty-seven percent have a
television set and 50% have a computer in their own
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appliances [87], also reduces the parents’ control of the
programs that are transmitted. Television programs are
interrupted by many TV commercials that often propose
highly caloric and salty foods. Therefore children who
spend too much time watching TV may also be those
who present the worst nutritional habits [88,89]. Schools
are also responsible for the scarce physical activity of
children and adolescents. In addition to school hours
with little sport activities much time is spent doing
homework. Furthermore there is little space in school
programs for promoting healthy lifestyle and nutrition.
Table 9 summarizes the measures to be taken in the case
of hypertension in children. Even though multiple and
coordinated awareness campaigns aiming at a correct
lifestyle are advisable, the child’s family still remains the
main environment for teaching the right habits espe-
cially through the parents’ example. The detection of in-
creased blood pressure levels in a child may stimulate
the improvement of the entire family’s lifestyle. Whereas
parents and teachers usually are receptive to the mes-
sage that healthy lifestyle and nutrition prevent chronic
degenerative diseases, young people do not show much,
if any, interest in this kind of approach. Other motiva-
tions should be emphasized such as physical fitness,
good looks, improvement of school and sport perfor-
mances, all obtainable by healthy dietary and behavioral
habits. It should be the task of the Family Pediatrician to
convey these messages in an appropriate and balanced
manner.Table 10 Therapeutic management of hypertension
Evidence in favor of therapeutic
management
• Reduce mortality and sequelae in the
• Reduce left ventricular hypertrophy
• Reduce urinary albumin excretion
• Reduce rate of progression to end-st
When to start antihypertensive
treatment
• Non-pharmacological therapy should
hypertension
• Non-pharmacological therapy should
• Pharmacological therapy should be in
damage, secondary hypertension or d
• Pharmacological therapy should be c
in the case of severe obesity with ass
following positive results with lifestyl
BP targets
• In general: blood pressure below the
• Chronic kidney disease: blood pressu
percentile in cases of proteinuria (urin
Lurbe et al. “Management of High Blood Pressure in Children and Adolescents: recoPharmacological therapy
Pharmacological therapy, when needed, should not in
any condition exclude dietary and behavioral therapy as
the latter may allow dose reduction of drugs, better
therapeutic control and more effective prevention of
other cardiovascular risk factors.
Drug treatment should be started in hypertensive
children with organ damage or kidney disease when blood
pressure values exceed the limits indicated in the treatment
goals (see Table 10). As univocal recommendations on the
pharmacological treatment of primary hypertension in
subjects without organ damage are not available, each of
these conditions should be evaluated individually. Pharma-
cological treatment is needed in the presence of blood
pressure values that remain above the 95th percentile unless
non-pharmacological interventions and in the case of initial
organ damage (particularly increase in left ventricular
mass). Drug therapy should be considered in the presence
of severe obesity with concomitant diseases, and may later
on be interrupted following a positive response to the
dietary-behavioral interventions. The drugs that are
currently recommended for the treatment of hyper-
tension in adults are also prescribed for children and
adolescents (Table 11): a) renin-angiotensin-aldoster-
one system blockers, ACE-inhibitors [90-92] and AT1-re-
ceptor antagonists, sartans [93-95] (aliskiren, a direct renin
inhibitor has not been evaluated in pediatric studies yet); b)
beta-blockers [96]; c) calcium-antagonists [97]; d) diuretics
[98]. Both renin-angiotensin-aldosterone system blockers
and beta-blockers reduce blood pressure by inactivation oflong-term
age renal disease
be initiated in all children with high normal blood pressure or
be continued after starting pharmacological therapy
itiated when patients have symptomatic hypertension, target organ
iabetes mellitus type 1 or 2
onsidered in the presence of clear increases in blood pressure levels or
ociated clinical conditions. Pharmacological therapy may be interrupted
e and dietary changes
90th percentile, specific for age, sex and height
re below the 75th percentile without proteinuria and below the 50th
e total protein creatinine ratio >0.20 mg/mg)
mmendations of the ESH”. Journal of Hypertension 2009 [2] (modified).
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peripheral vascular resistance (R drugs). Calcium antago-
nists exert a direct vasodilatory effect, while diuretics in-
crease natriuresis and reduce blood volume (V drugs). In
subjects with preserved renal function the blood pressure
lowering efficacy is practically identical for renin-
angiotensin-aldosterone system blockers, beta-blockers,
calcium antagonists and diuretics. In diabetics and in
the presence of kidney disease, especially with patho-
logical proteinuria, renin-angiotensin-aldosterone system
blockers should be preferred [99,100].
In practice it would be advisable to use drugs with
prolonged effects (retard formulations should be
avoided as they are badly absorbed by children and
loose their prolonged effect once the tablets are
split) and also to prescribe drugs with the least side
effects. Adverse side effects are most frequent with
diuretics, followed by beta-blockers, calcium antago-
nists, ACE-inhibitors and finally sartans. Almost
none of the drugs used for treating hypertension has
specific pediatric formulations. When tablets are
divided or pulverized for use in children they often
assume a distasteful flavor. The thiazide diuretics
hydrchlorothiazide and chlorthalidone, the calcium
antagonist lercanidipine and the AT1-receptor blocker
candesartan do not have any flavor and therefore theyTable 11 Drugs used for the treatment of hypertension in chi




















Retard formulations are unsuitable as they are often badly absorbed in children (ancan easily be administered in little children. Treat-
ment should start with a single drug. If the blood
pressure goal is not reached within 4–8 weeks the
dose should be increased or a second drug should be
added. Not all drug combinations are rational: an R
drug (renin-angiotensin-aldosterone system blocker or
beta-blocker) can reasonably be associated with a V
drug (calcium antagonist or diuretic). In clinical prac-
tice fixed drug combinations are often used, the most
frequently employed combination being an ACE-
inhibitor plus a thiazide diuretic. The intervention of
a specialist is always necessary when the patient
weighs less than 10–15 kg, when the blood pressure
goal is not reached after two drug treatment and in
the presence of impaired renal function (in this situ-
ation thiazide diuretics are ineffective and should be
replaced by loop diuretics such as furosemide).
Conclusions
The present document endorses the recent recommenda-
tions of the European Society of Hypertension and repre-
sents their translation into the Italian clinical reality. Two
specific aspects characterize our country regarding the
hypertension problem among the pediatric population.
On the one hand Italy, and especially the southern re-
gions, is one of the leading European countries forldren and adolescents, which on the basis of their long
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d when split in two the prolonged effect of these formulations disappears).
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widespread organization of the primary health care of chil-
dren and adolescents in the whole country. The increase of
excess weight in children and adolescents may cause a rise
in hypertension and other risk factors that are associated
with overweight and obesity. The important increase of car-
diovascular diseases that will arise once the present young
generations will become adults is of great concern. Suffi-
cient resources could become available to avert this
phenomenon, provided that the entire society together with
physicians and pediatricians in particular become aware of
the severity and the urgency of the problem. For this reason
preventive strategies such as promoting healthy lifestyle
and nutrition as well as limiting salt and alcohol intake and
quitting cigarette smoking are necessary. However, these
general measures should be assisted by procedures aiming
at revealing specific and individual cardiovascular risk fac-
tors. Blood pressure measurement of children and adoles-
cents is definitely the most simple and economic of these
procedures. This practice will reveal an important number
of subjects with increased blood pressure values thus stimu-
lating both the institutions that take care of children’s health
(families, schools, societies, political decision makers at
different levels) and scientific research workers. According
to the recommendations of the European Society of
Hypertension [2], the future goals are:
 Development of accurate non-mercury
sphygmomanometer for auscultatory blood pressure
measurement and accurate automatic devices for
oscillometric blood pressure measurement and
careful comparison of the two methods in children
and adolescents
 Implementation of reference values for office, 24h
ambulatory and self-measured blood pressure in
children and adolescents
 Increase the knowledge of the use of out-of-office
blood pressure measuring systems in children and
adolescents
 Collect data on early organ damage in order to allow
risk stratification and to define treatment goals
 Conduct large, long-term randomized therapeutic
trials on the onset of early organ damage
(microalbuminuria and/or left ventricular
hypertrophy) to obtain information about when to
start pharmacological therapy and about the blood
pressure goals to achieve
 Conduct controlled studies to define the advantages
and disadvantages of antihypertensive treatment and
establish adequate doses in children and adolescents
The efforts and investments in the field of prevention
and treatment of hypertension and of cardiovascular risk
in general, when started in childhood, may have a verypositive effect both on health and on saving of economic
resources.
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